Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Sarcoma, Alveolar Soft Part × ARQ 197 × Genitourinary × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Genitourinary 1

Conditions

Carcinoma, Renal Cell 4 Melanoma 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Sarcoma, Clear Cell 1 Sarcoma, Alveolar Soft Part 1 Ovarian Neoplasms 1 Neoplasms 1

Interventions

fludarabine 1 Radiotherapy 1 Ifosfamide 1 Filgrastim 1 Doxorubicin 1 Cyclophosphamide 1 Chemotherapy, Adjuvant 1 ARQ 197 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00557609 2013-02-08

Phase 2 Study in Patients With MiT Tumors

ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)

Phase 2 Completed

GenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Clear Cell, Sarcoma, Alveolar Soft Part

Data powered by HemOnc (CC BY 4.0) Colophon ⚡